300 Participants Needed

BrotherlyACT for Youth Violence and Substance Use

(BrotherlyACT Trial)

CN
Overseen ByChuka N Emezue, PhD, MPH
Age: < 65
Sex: Male
Trial Phase: Academic
Sponsor: Rush University Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This study will adapt and test a culturally tailored, multi-component, and trauma-focused digital intervention to reduce the risk and effects of youth violence and substance use and bridge service access gaps for young Black males (YBM) in pediatric emergency and community-based low-resource settings.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment BrotherlyACT for youth violence and substance use?

Research on similar treatments, like Integrated Family and Cognitive-Behavioral Therapy (IFCBT), shows significant reductions in substance use among adolescents, suggesting that family-based and cognitive-behavioral approaches can be effective. Additionally, technology-assisted interventions like Parent SMART have shown promise in engaging parents and reducing substance use in adolescents, indicating that combining technology with therapy may enhance outcomes.12345

Is BrotherlyACT safe for humans?

The research on Integrated Family and Cognitive-Behavioral Therapy (IFCBT), which may be similar to BrotherlyACT, found no harmful effects in youth participants, suggesting it is generally safe for humans.23467

How is the BrotherlyACT treatment different from other treatments for youth violence and substance use?

BrotherlyACT is unique because it combines technology with Acceptance and Commitment Therapy (ACT) to empower youth, reduce risks, and build life skills, which is different from traditional therapies that may not integrate technology or focus on these specific areas.34689

Research Team

CN

Chuka N Emezue, PhD, MPH

Principal Investigator

Rush University Medical Center

Eligibility Criteria

This trial is for young Black males who may be at risk of or affected by youth violence and substance use. It aims to help those in low-resource communities, particularly those who visit pediatric emergency services.

Inclusion Criteria

Black/African American hospitalized for injury
English literate at a 5th-grade reading level or higher
Assault-injured youth without impairments (e.g., unstable injuries)
See 3 more

Exclusion Criteria

Currently detained in the criminal justice system
Those presenting with a chief complaint of acute sexual assault, suicidal ideation or attempt, or child maltreatment will be excluded as they already receive other ED services
I am able to understand and sign consent forms without language, mental health, or cognitive issues.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the BrotherlyACT digital intervention, including psychoeducational modules, a Safety Planning Toolkit, and a Service Engagement Chatbot

3 months
Baseline, 1-month, and 3-month follow-ups

Follow-up

Participants are monitored for changes in youth violence, substance use, and psychological outcomes

3 months
1-month and 3-month follow-ups

Treatment Details

Interventions

  • BrotherlyACT
Trial Overview The study is testing BrotherlyACT, a culturally tailored digital intervention designed to reduce youth violence and substance use among participants. The effectiveness will be compared with a waitlist control group that does not receive the intervention immediately.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Waitlist Control Group (WCG)Experimental Treatment1 Intervention
Waitlist Control Group (WCG)
Group II: BrotherlyACT Intervention GroupExperimental Treatment1 Intervention
Three components make up BrotherlyACT: 1) Brief psychoeducational modules adapted from an evidence-based violence prevention program; 2) A Safety Planning Toolkit offering tools for risk assessment, mood tracking, goal setting, and mindfulness-based stress reduction; 3) A Service Engagement Chatbot that uses NLP to provide zip-code based navigational support and talk therapy.

BrotherlyACT is already approved in United States for the following indications:

🇺🇸
Approved in United States as BrotherlyACT for:
  • Youth violence prevention
  • Substance use prevention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rush University Medical Center

Lead Sponsor

Trials
448
Recruited
247,000+

Findings from Research

Adolescent substance use can lead to serious long-term issues such as dependence, criminal behavior, and mental health disorders, highlighting the need for effective family-based interventions.
The article reviews various evidence-based family treatments for adolescent substance use, including multisystemic therapy and functional family therapy, emphasizing their outcomes and implementation factors to help clinicians choose the best approach.
Family-Based Treatments for Adolescent Substance Use.Horigian, VE., Anderson, AR., Szapocznik, J.[2020]
The Parent SMART intervention, which combines an online parenting program with coaching and networking, was found to be acceptable and feasible for engaging parents of adolescents in residential treatment for substance-related issues.
Preliminary results suggest that adolescents in short-term residential care whose parents participated in Parent SMART had fewer days of alcohol use and fewer school problems compared to those whose parents only received traditional treatment, indicating potential effectiveness of the intervention.
Parent SMART (Substance Misuse in Adolescents in Residential Treatment): Pilot randomized trial of a technology-assisted parenting intervention.Becker, SJ., Helseth, SA., Janssen, T., et al.[2022]
Integrated Family and Cognitive-Behavioral Therapy (IFCBT) significantly reduced substance use in adolescents compared to the Drugs Harm Psychoeducation curriculum (DHPE), with IFCBT participants using alcohol an average of 2.03 days per month versus 6.06 days for DHPE participants, and marijuana 5.67 days versus 13.83 days, respectively.
IFCBT not only decreased substance use but also improved psychosocial skills in youth and adaptive communication and involvement in parents, indicating its effectiveness in addressing both individual and family dynamics in treating adolescent drug abuse.
Integrated family and cognitive-behavioral therapy for adolescent substance abusers: a stage I efficacy study.Latimer, WW., Winters, KC., D'Zurilla, T., et al.[2019]

References

Family-Based Treatments for Adolescent Substance Use. [2020]
Parent SMART (Substance Misuse in Adolescents in Residential Treatment): Pilot randomized trial of a technology-assisted parenting intervention. [2022]
Integrated family and cognitive-behavioral therapy for adolescent substance abusers: a stage I efficacy study. [2019]
Intervention for marijuana using, court-involved non-incarcerated youth. [2023]
Factors associated with treatment compliance in a population of juvenile sexual offenders. [2017]
Proximal Outcomes of Connecting, an Evidence-based, Family-focused Prevention Program for Caregivers of Adolescents in Foster Care. [2022]
Diagnostic accuracy of the Child and Adolescent Symptom Inventory (CASI-4R) substance use subscale in detecting substance use disorders in youth. [2023]
Multidimensional Family Therapy for Justice-Involved Young Adults with Substance Use Disorders. [2023]
Alcohol abuse prevention among high-risk youth: computer-based intervention. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security